107 related articles for article (PubMed ID: 3705020)
1. Evidence that low molecular fibrinogen (LMW) is formed in man by degradation of high molecular weight fibrinogen (HMW).
Holm B; Nilsen DW; Godal HC
Thromb Res; 1986 Mar; 41(6):879-84. PubMed ID: 3705020
[No Abstract] [Full Text] [Related]
2. Half life and incorporation into venous thrombi of the normally occurring plasma fibrinogen fractions HMW and LMW.
Holm B; Nilsen DW; Godal HC
Thromb Res; 1986 Jan; 41(1):57-66. PubMed ID: 3961727
[TBL] [Abstract][Full Text] [Related]
3. Polymerization properties of two normally circulating fibrinogens, HMW and LMW. Evidence that the COOH-terminal end of the a-chain is of importance for fibrin polymerization.
Holm B; Brosstad F; Kierulf P; Godal HC
Thromb Res; 1985 Sep; 39(5):595-606. PubMed ID: 4082102
[TBL] [Abstract][Full Text] [Related]
4. In vivo stability of cryoprecipitate fibrinogen.
Sherman LA
Transfusion; 1977; 17(1):59-61. PubMed ID: 841675
[TBL] [Abstract][Full Text] [Related]
5. Evidence that changes in fibrinogen quality during acute phase reactions are of major importance for the amount of heparin precipitable fraction (HPF).
Holm B; Godal HC
Thromb Res; 1985 Aug; 39(4):449-58. PubMed ID: 4049325
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma.
Holm B; Nilsen DW; Kierulf P; Godal HC
Thromb Res; 1985 Jan; 37(1):165-76. PubMed ID: 3983897
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogen.
Dempfle CE; Pfitzner SA; Schott D; Niessen KH; Heene DL
Thromb Haemost; 1997 May; 77(5):879-83. PubMed ID: 9184396
[TBL] [Abstract][Full Text] [Related]
8. The viscosity of fibrinogen subfractions and of EDTA denatured fibrinogen do not differ from that of native fibrinogen.
Jensen T; Halvorsen S; Godal HC; Sandset PM; Skjønsberg OH
Thromb Res; 2004; 113(1):51-6. PubMed ID: 15081565
[TBL] [Abstract][Full Text] [Related]
9. Interactions of human blood platelets with three circulating plasma fibrinogens of different molecular weights.
Thorsen LI; Holm B; Brosstad F; Solum NO
Thromb Res; 1987 Sep; 47(6):683-92. PubMed ID: 3686483
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures.
Lipinska I; Lipinski B; Gurewich V; Hoffmann KD
Am J Clin Pathol; 1976 Dec; 66(6):958-66. PubMed ID: 998569
[TBL] [Abstract][Full Text] [Related]
11. A rapidly produced 125I labelled autologous fibrinogen: in vitro properties and preliminary metabolic studies in man.
Hawker RJ; Hawker LM
J Clin Pathol; 1976 Jun; 29(6):495-501. PubMed ID: 939805
[TBL] [Abstract][Full Text] [Related]
12. Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogen.
Lipinski B; Lipinska I
Magnes Res; 2000 Dec; 13(4):233-7. PubMed ID: 11153893
[TBL] [Abstract][Full Text] [Related]
13. [Study on fibrinogen kinetics in pregnant rabbits].
Mahn I; Möller RM; Müller-Berghaus G
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1156-8. PubMed ID: 611811
[No Abstract] [Full Text] [Related]
14. Extraction, radioiodination, and in vivo catabolism of equine fibrinogen.
Coyne CP; Hornof WJ; Kelly AB; O'Brien TR; DeNardo SJ
Am J Vet Res; 1985 Dec; 46(12):2572-7. PubMed ID: 4083596
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen kinetics in chronic renal failure of various causes.
Ardaillou N; Sraer JD; Beaufils P
Biomedicine; 1974 Jan; 21(1):49-56. PubMed ID: 4844175
[No Abstract] [Full Text] [Related]
16. Clearance characteristics of des-AA fibrin and des-AABB fibrin, and thrombus-related uptake of des-AABB fibrin as compared to fibrinogen.
Nilsen DW; Brosstad F; Holm B; Kierulf P; Godal HC
Scand J Clin Lab Invest Suppl; 1985; 178():115-9. PubMed ID: 3867112
[TBL] [Abstract][Full Text] [Related]
17. Studies on the catabolism and distribution of fibrinogen in rats. Application of the Iodogen labelling technique.
Nieuwenhuizen W; Emeis JJ; Vermond A; Kurver P; van der Heide D
Biochem Biophys Res Commun; 1980 Nov; 97(1):49-55. PubMed ID: 7006608
[No Abstract] [Full Text] [Related]
18. 125I versus 75se labeling of fibrinogen for measuring turnover of canine fibrinogen.
Owen CA; Bowie EJ
Proc Soc Exp Biol Med; 1974 Jun; 146(2):349-51. PubMed ID: 4834441
[No Abstract] [Full Text] [Related]
19. A local uPAR-plasmin-TGFβ1 positive feedback loop in a qualitative computational model of angiogenic sprouting explains the in vitro effect of fibrinogen variants.
Boas SEM; Carvalho J; van den Broek M; Weijers EM; Goumans MJ; Koolwijk P; Merks RMH
PLoS Comput Biol; 2018 Jul; 14(7):e1006239. PubMed ID: 29979675
[TBL] [Abstract][Full Text] [Related]
20. [Letter: The half-life of labelled fibrinogen during acute diseases].
Larcan A; Robert J; Lambert H; Hennequin G; Mabille H
Nouv Presse Med; 1976 Feb; 5(9):587. PubMed ID: 1264728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
